| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3875956 | The Journal of Urology | 2013 | 4 Pages |
Abstract
By decreasing the contribution to prostate specific antigen from benign prostatic hyperplasia finasteride makes changes in prostate specific antigen more cancer specific. This effect may explain the increased detection of high grade prostate cancer in men randomized to finasteride in the Prostate Cancer Prevention Trial. How to best use prostate specific antigen to recommend biopsy in men on 5α-reductase inhibitors requires further study.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Anthony V. D'Amico, Michael J. Barry,